<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01339065</url>
  </required_header>
  <id_info>
    <org_study_id>MUK CHS</org_study_id>
    <nct_id>NCT01339065</nct_id>
  </id_info>
  <brief_title>The Effect of Ketamine on Production of Inflammatory Markers in Post Operative Patients in Mulago Hospital</brief_title>
  <official_title>The Effect of Ketamine on Production of Inflammatory Markers in Post Operative Patients in Mulago Hospital: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Makerere University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      . Null Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult patients
      undergoing elective surgery, in Mulago hospital, will not have a reduction effect on the
      levels of IL-6 &amp; IL-1β pro inflammatory markers by 48 hours.

      . Alternate Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult
      patients undergoing elective surgery, in Mulago hospital, will have a reduction effect on the
      levels of IL-6 &amp; IL-1β pro inflammatory markers by 48 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RESEARCH QUESTION Can 0.5mg/kg of Ketamine given preoperatively have an effect on the levels
      of pro-inflammatory markers?

      Primary specific Outcome: changes/deviations from baseline levels of IL- 6 pro-inflammatory
      markers of after surgery at PACU, 24 and 48 hours.

      Secondary specific Outcome: changes/deviations from baseline levels of IL-1β pro-inflammatory
      markers of after surgery at PACU, 24 and 48 hours.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes/deviations from baseline levels of IL-6 pro-inflammatory markers of after surgery</measure>
    <time_frame>48 hours</time_frame>
    <description>changes/deviations from baseline levels of IL-6 pro-inflammatory markers of after surgery at Post Anesthesia Care Unit, 24 and 48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes/deviations from baseline levels of IL-1β pro-inflammatory markers of after surgery</measure>
    <time_frame>48 hours</time_frame>
    <description>changes/deviations from baseline levels of IL-1β pro-inflammatory markers of after surgery at PACU, 24 and 48 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Post Operative Inflammatory Marker Levels</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will be given low sub-anesthetic doses of Ketamine 0.5mg/kg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will get placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>determining the effect of low dose sub anesthetic doze of ketamine and placaebo on post operative patients</description>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consented patients due for elective surgery

          -  Adult patients 18- 70 year old

          -  ASA I- ASA II scoring patients, who are normal patients or those with mild systemic
             illness

        Exclusion Criteria:

          -  Emergency cases that will already have high levels of inflammatory markers secreted in
             their system by incision time e.g. road traffic accidents

          -  Patients with chronic / severe hypertension

          -  Febrile Patients (T &gt;38°C)

          -  Persistently raised blood pressures above 140/90 for 2 consistent readings 15 minutes
             apart

          -  Patients with pheochromocytoma

          -  Spinal and local infiltration anaesthesia cases

          -  Neuro surgery patients whom Ketamine is contra indicated

          -  Epilepsy patients

          -  ASA IIIE and above

          -  Patients receiving Aspirin prophylaxis

          -  Chronic inflammatory disease states such as hyperparathyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mulago Hospital National Refferal, surgical wards</name>
      <address>
        <city>Kampala</city>
        <zip>+256</zip>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John M Kasumba, MBChB, MMed Anaesthesia- MUK</last_name>
      <phone>+25675625678</phone>
      <phone_ext>+256701625678</phone_ext>
      <email>drkasmaya@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tonny S Luggya, MBChB- MUK</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>April 19, 2011</last_update_submitted>
  <last_update_submitted_qc>April 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr luggya Tonny Stone</name_title>
    <organization>Makerere University, College Of Health Sciences</organization>
  </responsible_party>
  <keyword>ketamine</keyword>
  <keyword>inflammatory</keyword>
  <keyword>pro inflammatory</keyword>
  <keyword>pro inflammatory markers IL-6 and IL-1beta</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

